Managing oral mucositis in patients with hematologic malignancies.
D004999:Amifostine / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects; D017679:Cryotherapy; D051523:Fibroblast Growth Factor 7 / Q000627:therapeutic use; D019337:Hematologic Neoplasms / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D011837:Radiation-Protective Agents / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013280:Stomatitis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D014916:Whole-Body Irradiation / Q000009:adverse effects
D000970:Antineoplastic Agents; D011837:Radiation-Protective Agents; D051523:Fibroblast Growth Factor 7; D004999:Amifostine